Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
are looking for someone with expertise in genomic data handling, to: (i) Use and/or develop bioinformatics tools to create schemes, i.e., lists of gene loci carefully selected for genotyping purposes; (ii
-
must have a PhD degree (or being in the process of completing one) in a relevant subject with a demonstrated track record of productive research. Candidates are highly motivated to develop/conduct
-
Candidate background: we are looking for an excellent candidate with the following qualifications, knowledge and skills: - A PhD in geochemistry or geomicrobiology, - A strong ability to design and carry out
-
FieldPharmacological sciencesYears of Research Experience1 - 4 Additional Information Eligibility criteria • PhD in Computational Chemistry, Biophysics, Bioinformatics, or a related field. • Strong expertise in
-
or equivalent Skills/Qualifications PhD in immunology or solid background in immunology Skills in cell sorting, single cell and/or single nuclei, AIIRseq, RNASeq Skills in bioinformatics Candidate will provide
-
June 2024. The team is directed by Salomon MANIER (MD, PhD) and Suman MITRA (CRCN) and is focused on tumor persistence and immune response in hematological malignancies. The lab is part of the Canther
-
FieldBiological sciences » OtherEducation LevelPhD or equivalent Skills/Qualifications Operational skills Proven experience in bioinformatics, genomics, population genetics and/or cancer biology. Experience in
-
patients hospitalized in France at a national level using data from French health databases (SNDS). Applicants should have a Master or Engineering degree or PhD in Biostatistics or Bioinformatics
-
communication skills and team spirit, and an ability to work in autonomy are essential. Fluent English both spoken and written is required. Degree: PhD level in computer science, machine learning, bioinformatics
-
Structural Bioinformatics unit of Pr Michael Nilges. Project background: Among the various molecular mechanisms of antibiotic resistance, changes in antibiotic target by mutation, and reduced access